Definiens Symposium 2012

The 3rd International Definiens Symposium was held in Munich, Germany, June 14-16, 2012.

The Symposium opened with a day of workshops at the Definiens headquarters in Munich's emerging Arnulfpark district. Two days of plenary lectures at the nearby Ernst & Young auditorium covered a wide variety of aspects in biomedical image and data analysis.
Definiens thanks all participants of the 3rd International Definiens Symposium for inspiring presentations, fruitful discussions and a stimulating atmosphere. We enjoyed meeting you and exchanging ideas during plenary sessions, workshops, coffee breaks and the evening events. Recordings of plenary lectures and a photo gallery provide impressions of the event.

Welcome
Thomas Heydler, CEO
Definiens, Munich, Germany

Quantitative Image Analysis in Preclinical and Clinical Drug Discovery - Why Count when you can Code?
Dr Frauke Bentzien, Director Clinical Science
Exelixis, San Francisco, CA

Context Driven Image Analysis and Image Mining: Indispensable Tools for the Future of Medicine
Nobel Laureate Prof Dr Gerd Binnig, Founder and CTO
Definiens, Munich, Germany

Translational Lung Cancer Research
Prof Dr Sven Perner, Department of Prostate Cancer Research
Institute of Pathology, University Hospital Bonn, Germany

Image Analysis in Translational Research - Benefits and Challenges within Pharmaceutical R&D
Dr Lorcan Sherry, Director
OracleBio, Glasgow, UK

Unlocking the Value of Digital Pathology with Image Analysis
Ole Eichhorn, CTO
Aperio, Vista, CA

HistoQuant Mamma: Computer-assisted Breast Cancer Diagnostics
Prof Dr Manfred Dietel, Director, Institute of Pathology
Charité, Berlin, Germany

Integration of Digital Imaging and Stereological Techniques in the Development of Biomarker Assays for Discovery Research and Clinical Trials
Dr Valerie Croons, Imaging Scientist Technical Supervisor
HistoGeneX, Berchem, Belgium

Next Generation Histopathology: Definiens Software Applications in Discovery Research in the Pharmaceutical Industry
Dr Carole Chotard, Principal Scientist
Institut de Recherches Servier, Croissy sur Seine, France

The Changing Perspective of Image Analysis for Investigative and Translational Pathology in Drug Discovery
Alison Bigley CSci, FIBMS, Team Leader Analytical Morphology, Global Safety Assessment
AstraZeneca R&D Innovative Medicines, Alderley Park, UK

Comprehensive Image Analysis of Pancreatic Islets in Pre-clinical Models
Dr Elena Kleymenova, Senior Scientific Investigator
GlaxoSmithKline, Research Triangle Park, NC

Quantitative Digital Pathology at Novartis: Examples from Disease Model Validation Studies in Research
Dr Arno Doelemeyer, Senior Investigator I
PCS Pathology, Novartis Pharma, Basel, CH

Digital Pathology in Preclinical Sciences: Contribution of 3D Ovary Reconstruction
Erio Barale-Thomas, Principal Scientist Pathology
Johnson & Johnson Pharmaceutical R&D, Beerse, Belgium

Implementing a Clinical Multivariate Index Assay using CRi Vectra and Definiens Developer
Dr Tom Nifong, Vice President of Clinical Operations
Metamark Genetics, Cambridge, MA

Healthcare Everywhere: A Shift of the Epicenter of Healthcare Toward the Patient
Dr Frank Kumli, Senior Manager, Advisory Services
Ernst & Young, Basel, CH

Definiens' Next Moves: An Integrated Environment for Quantitative Digital Pathology
Dr Martin Baatz, VP Marketing
Definiens, Munich, Germany

Elucidating the Mechanisms of Tumor-Stroma Interaction in Prostate Cancer
Mark Lloyd, Core Staff Scientist, Analytic Microscopy Core Facility
H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Image Mining in Robustness Testing and Quality Control of Duplex Immunohistochemistry To Detect Truncated Forms of the HER2 Receptor in Breast Cancer
Dr Friedrich Feuerhake, Head of Experimental Pathology
Roche Diagnostics, Penzberg, Germany

Integrating Data Mining with Image Analysis: Definiens Image Miner 2
Arno Schaepe, VP Product Development
Definiens, Munich, Germany

Quantitative Single-Cell Immunofluorescence to Identify Patient Populations for MM-302 Development
Dr Elena Geretti, Senior Scientist
Merrimack Pharmaceuticals, Cambridge, MA

Quantitative Description of Fungal Morphology by Automated Image Analysis
Franziska Mech, Applied Systems Biology
Leibniz-Institute for Natural Product Research and Infection Biology HKI, Jena, Germany

2D and 3D Image Processing and Analysis for the Quantification of Complex Cellular Features
Dr Christophe Jung, Scientist, Facility Manager
Gene Center Munich, Germany

From Aging Tubuli to Proliferating Neuroblasts - Definiens in a Mulituser Facility
Gerald Schmauss, BioOptics Facility
Institute of Molecular Pathology, Vienna, Austria

Current Role of Image Analysis in Tissue-based Research at the Helmholtz Zentrum München
Dr Annette Feuchtinger, Research Scientist
Research Unit Analytical Pathology, German Research Center for Environmental Health, Helmholtz Zentrum Munich, Germany

Definiens Tissue Studio and Developer XD: Product Hands-On
Instructors: Dr Daniela Längin, Dr Björn Reiss, Dr Nicolas Brieu

Introduction to Definiens Image Miner
Instructors: Arno Schäpe, Melanie Görner

Advanced Rule Set Development for Tissue Analysis using Definiens Developer XD: Bring Your Own
Instructors: Dr Barbara Zenger-Landolt, Dr Christian Sendner

Advanced Rule Set Development on Multidimensional Data using Definiens Developer XD: Bring Your Own
Instructors: Dr Günter Schmidt, Dr Sau-Mei Leung

Setting Up Architect Libraries in Definiens Developer XD: Build Your Own App
Instructors: Dr Christian Böhringer-Shahidi, Daniel Martens